PHAXIAM Therapeutics: Detailed Company Information & Corporate Profile
Summary
PHAXIAM Therapeutics is a public company that has been in the industry for 22 years. The business currently specializes in Biotechnology, Pharmaceuticals, Biotechnology areas. PHAXIAM Therapeutics's headquarter is located at Lyon, Rhône Alpes, FR. The number of employees is at least 100. Register with SignalHire to connect with PHAXIAM Therapeutics employees and management.
| PHAXIAM Therapeutics Website | phaxiam.com |
| Social Links |   |
| Phone Number | 0478744438 |
| Industries | |
| PHAXIAM Therapeutics Headquarters address | 60 avenue Rockefeller, LYON, Rhône-Alpes, 69008 FR |
| Company Size | 100-200 employees |
| Specialties | Biotechnology, phage, innovation, bacterial infection, viruses, staphylococcus aureus, escherichia coli, pseudomonas aeruginosa, phxm |
| SIC Code | 2834, 2836 |
| Founded | 2004 |
| Operating Status | Independent Company |
Competitors
Name | Founded | Type | Employees |
|---|---|---|---|
| 2013 | Public Company | 1.0K - 5.0K | |
| 2013 | Public Company | 100 - 250 | |
| 1997 | Public Company | 100 - 250 | |
| 2014 | Privately Held | 1 - 25 |
Workforce Turnover
Length of Employment
PHAXIAM Therapeutics's workforce includes employees across a wide range of tenure levels.
5% have been with the company for 1 to 2 years5% have been with the company for 3 to 4 years17% have been with the company for 5 to 7 years34% have been with the company for 8 to 10 years39% have been with the company for more than 11 years
Companies Similar to PHAXIAM Therapeutics
PHAXIAM Therapeutics Corporate Information: FAQ
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.
